AstraZeneca Launches $1.5 Billion Cost-Savings Program
AstraZeneca said it is launching the program to free up resources for investment in its drug pipeline.
By Adria CalatayudAstraZeneca said it is launching a $1.5 billion cost-savings program, as the U.K. drugmaker seeks to free up resources to invest in its drug pipeline.The company disclosed the plan on Friday alongside its third-quarter results, which showed increases in revenue and profit after st…